| N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 M McCallum, A De Marco, FA Lempp, MA Tortorici, D Pinto, AC Walls, ... Cell 184 (9), 2332-2347. e16, 2021 | 934 | 2021 |
| Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms MA Tortorici, M Beltramello, FA Lempp, D Pinto, HV Dang, LE Rosen, ... Science 370 (6519), 950-957, 2020 | 550 | 2020 |
| Favipiravir as a potential countermeasure against neglected and emerging RNA viruses L Delang, R Abdelnabi, J Neyts Antiviral research 153, 85-94, 2018 | 497 | 2018 |
| SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape TN Starr, N Czudnochowski, Z Liu, F Zatta, YJ Park, A Addetia, D Pinto, ... Nature 597 (7874), 97-102, 2021 | 458 | 2021 |
| Broad betacoronavirus neutralization by a stem helix–specific human antibody D Pinto, MM Sauer, N Czudnochowski, JS Low, MA Tortorici, MP Housley, ... Science 373 (6559), 1109-1116, 2021 | 346 | 2021 |
| Favipiravir at high doses has potent antiviral activity in SARS-CoV-2− infected hamsters, whereas hydroxychloroquine lacks activity SJF Kaptein, S Jacobs, L Langendries, L Seldeslachts, S Ter Horst, ... Proceedings of the National Academy of Sciences 117 (43), 26955-26965, 2020 | 294 | 2020 |
| Broad sarbecovirus neutralization by a human monoclonal antibody MA Tortorici, N Czudnochowski, TN Starr, R Marzi, AC Walls, F Zatta, ... Nature 597 (7874), 103-108, 2021 | 237 | 2021 |
| Imprinted antibody responses against SARS-CoV-2 Omicron sublineages YJ Park, D Pinto, AC Walls, Z Liu, A De Marco, F Benigni, F Zatta, ... Science 378 (6620), 619-627, 2022 | 204 | 2022 |
| Towards antivirals against chikungunya virus R Abdelnabi, J Neyts, L Delang Antiviral research 121, 59-68, 2015 | 151 | 2015 |
| Molnupiravir inhibits replication of the emerging SARS-CoV-2 variants of concern in a hamster infection model R Abdelnabi, CS Foo, S De Jonghe, P Maes, B Weynand, J Neyts The Journal of infectious diseases 224 (5), 749-753, 2021 | 150 | 2021 |
| The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model R Abdelnabi, CS Foo, SJF Kaptein, X Zhang, TND Do, L Langendries, ... EBioMedicine 72, 2021 | 140 | 2021 |
| Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry YJ Park, A De Marco, TN Starr, Z Liu, D Pinto, AC Walls, F Zatta, ... Science 375 (6579), 449-454, 2022 | 135 | 2022 |
| The omicron (B. 1.1. 529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters R Abdelnabi, CS Foo, X Zhang, V Lemmens, P Maes, B Slechten, ... Antiviral research 198, 105253, 2022 | 130 | 2022 |
| ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies JS Low, J Jerak, MA Tortorici, M McCallum, D Pinto, A Cassotta, ... Science 377 (6607), 735-742, 2022 | 128 | 2022 |
| The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern R Abdelnabi, CS Foo, D Jochmans, L Vangeel, S De Jonghe, ... Nature Communications 13 (1), 719, 2022 | 127 | 2022 |
| Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters R Abdelnabi, R Boudewijns, CS Foo, L Seldeslachts, L Sanchez-Felipe, ... EBioMedicine 68, 2021 | 103 | 2021 |
| Understanding the mechanism of the broad-spectrum antiviral activity of favipiravir (T-705): key role of the F1 motif of the viral polymerase R Abdelnabi, ATS Morais, P Leyssen, I Imbert, S Beaucourt, H Blanc, ... Journal of virology 91 (12), 10.1128/jvi. 00487-17, 2017 | 78 | 2017 |
| Chikungunya virus infections: time to act, time to treat R Abdelnabi, J Neyts, L Delang Current opinion in virology 24, 25-30, 2017 | 60 | 2017 |
| An affinity-enhanced, broadly neutralizing heavy chain–only antibody protects against SARS-CoV-2 infection in animal models B Schepens, L van Schie, W Nerinckx, K Roose, W Van Breedam, ... Science Translational Medicine 13 (621), eabi7826, 2021 | 54 | 2021 |
| A novel druggable interprotomer pocket in the capsid of rhino-and enteroviruses R Abdelnabi, JA Geraets, Y Ma, C Mirabelli, JW Flatt, A Domanska, ... PLoS Biology 17 (6), e3000281, 2019 | 54 | 2019 |